Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 7, 2016; 22(37): 8414-8434
Published online Oct 7, 2016. doi: 10.3748/wjg.v22.i37.8414
Published online Oct 7, 2016. doi: 10.3748/wjg.v22.i37.8414
Ref. | Year | Local recurrence (LR) | P < 0.05 | Distant recurrence (DR) | P < 0.05 | Progression disease-free survival (DFS) | P < 0.05 | Disease-free survival (DFS) | P < 0.05 | Overall survival (OS) | P < 0.05 | Conclusion |
Shihab et al[52] | 2011 | Better in GR | No | Better in GR | Yes | Good responders have better, statistically significant outcomes for DR but have better, non significant LR | ||||||
Patel et al[5] and Patel et al[7] | 2011 and 2012 | Better in GR | No | Better in GR | Yes | Better in GR | Yes | Good responders have better, statistically significant outcomes for DFS and OS but have better, non significant outcomes for LR | ||||
Yu[53] | 2014 | Better in GR | Yes | Better in GR | Yes | Good responders have better, statistically significant outcomes for DFS and OS |
- Citation: Siddiqui MRS, Bhoday J, Battersby NJ, Chand M, West NP, Abulafi AM, Tekkis PP, Brown G. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales. World J Gastroenterol 2016; 22(37): 8414-8434
- URL: https://www.wjgnet.com/1007-9327/full/v22/i37/8414.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i37.8414